Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3815-3831, Vol. 74, No. 8
Plum Island Animal Disease Center,
Agricultural Research Service, U.S. Department of Agriculture,
Greenport, New York 11944
Received 15 December 1999/Accepted 26 January 2000
Here we present the genomic sequence, with analysis, of a
pathogenic fowlpox virus (FPV). The 288-kbp FPV genome consists of a
central coding region bounded by identical 9.5-kbp inverted terminal
repeats and contains 260 open reading frames, of which 101 exhibit
similarity to genes of known function. Comparison of the FPV genome
with those of other chordopoxviruses (ChPVs) revealed 65 conserved gene
homologues, encoding proteins involved in transcription and mRNA
biogenesis, nucleotide metabolism, DNA replication and repair, protein
processing, and virion structure. Comparison of the FPV genome with
those of other ChPVs revealed extensive genome colinearity which is
interrupted in FPV by a translocation and a major inversion, the
presence of multiple and in some cases large gene families, and novel
cellular homologues. Large numbers of cellular homologues together with
10 multigene families largely account for the marked size difference
between the FPV genome (260 to 309 kbp) and other known ChPV genomes
(178 to 191 kbp). Predicted proteins with putative functions involving immune evasion included eight natural killer cell receptors, four CC
chemokines, three G-protein-coupled receptors, two Within the
Chordopoxvirinae subfamily (poxviruses of vertebrates) of
the family Poxviridae, only members of the
Avipoxvirus genus infect nonmammalian hosts
(118). Avipoxviruses are a large family of cytoplasmic DNA
viruses which infect more than 60 species of wild birds representing 20 families (169). Variability in restriction enzyme profiles
of viral DNA suggests significant genomic differences among family
members (169). Cross-infection studies also suggest genetic
differences among viruses, which are reflected as a wide range of
pathogenic effects (absence of clinical disease, local pox lesions,
local and generalized infection, and generalized infection with death)
and a lack of cross protection, depending on the specific virus-host
combination (46, 169).
Fowlpox virus (FPV), the prototypical member of the
Avipoxvirus genus, infects chickens and turkeys. Poxvirus
diseases of poultry and other domestic birds (canaries and pigeons)
have significant economic impact worldwide, with losses resulting from
a drop in egg production in layers, reduced growth rates in broilers,
blindness, and in some cases death (46, 170). Two forms of
disease are associated with different routes of infection. The most
common, the cutaneous form, occurs following infection by biting
arthropods that serve as mechanical vectors for viral transmission. The
disease is characterized by an inflammatory process with hyperplasia of the epidermis and feather follicles, scab formation, and desquamation of the degenerated epithelium, and it predisposes the host to secondary
bacterial infections. The second, or diphtheric, form involves droplet
infection of the mucous membranes of the mouth, the pharynx, the
larynx, and sometimes the trachea. The prognosis with this form of the
disease is poor because lesions often cause death by asphyxiation
(169-171).
Vaccination with live-attenuated viruses (FPV and canarypox virus
[CaPV]) and nonattenuated viruses (pigeonpox virus) is used to
control this disease (59, 77, 136, 182). Fowlpox and pigeonpox vaccines are applied by comb scarification, by the wing-web stick method, or by feather follicle immunization. Vaccination confers
protective immunity 10 to 14 days after infection. Problems related to
safety and efficacy of commercial FPV vaccines remain (9, 24, 29,
65).
Multivalent recombinant FPV vaccines as well as FPV vaccines which
incorporate immune response modifiers have been constructed (28,
96). Recombinant FPV vaccines expressing foreign antigens have
been used to immunize animals against other avian and mammalian diseases (26, 83, 112, 121, 124, 125, 187). Because FPV and
CaPV undergo abortive replication in mammalian cells, their use as host
range-restricted mammalian expression vectors has been suggested
(164, 165).
The FPV genome, containing 260 to 309 kbp of double-stranded DNA, is
larger than other described chordopoxvirus (ChPV) genomes (45,
115, 120). Past work on FPV genomics, much of which used highly
tissue culture-passaged FPV strains, has provided genetic information
on approximately one-third of the viral genome, including some viral
genes with putative immune evasion and host range functions (16,
18, 20, 57, 93, 127, 150, 163, 166, 191). The rational design of
safer and more effective FPV vaccines and FPV-based expression vectors
will require complete information on viral genes associated with viral
virulence and host range and a more complete understanding of how these
genes function in viral pathogenesis, immune evasion, and avian host
range. Here we report the genomic sequence and analysis of a
highly pathogenic strain of FPV.
FPV DNA isolation, cloning, and sequencing.
FPV
genomic DNA was extracted from primary chicken embryo
fibroblasts infected with a pathogenic FPV strain (fowlpox challenge virus; Animal Health Inspection Service Center for Veterinary Biologics, Ames, Iowa). Random DNA fragments were obtained by incomplete enzymatic digestion with Tsp509I endonuclease
(New England Biolabs, Beverly, Mass.). DNA fragments of 1.5 to 2.5 kbp
were isolated after separation on agarose gels, cloned into the
dephosphorylated EcoRI site of pUC19 plasmids, and grown in Escherichia coli DH10B cells (Gibco BRL, Gaithersburg, Md.).
Double-stranded pUC19 plasmids were purified by the alkaline lysis
method in accordance with the manufacturer's instruction (5' DNA sequence analysis.
Genome DNA composition, structure,
repeats, and restriction enzyme patterns were analyzed as previously
described (1). Open reading frames (ORFs) longer than 30 amino acids with a methionine start codon (155, 156) were
evaluated for coding potential by the use of the Hexamer
(ftp.sanger.ac.uk/pub/rd) and Glimmer (134) computer
programs. Minor ORFs were excluded. Gene families were analyzed and
annotated as previously described (1). Early-promoter sequences were predicted as follows. Fifteen-base DNA motifs with similarity to the vaccinia virus (VV) early-promoter consensus sequence
(51, 118) were selected from regions located upstream of
initiation codons of 30 FPV homologues of VV virus early genes. These
motifs were used to generate a scoring matrix (PROFILEMAKE) (55), and this matrix was used to search 100 bases upstream of all FPV ORFs (MOTIFSEARCH) (55). Positive ORFs found by
MOTIFSEARCH (P = 0.001) were further verified by visual
inspection, and those that had substitutions at the most-conserved
residues were excluded (14 genes).
Virus abbreviations.
Virus names are abbreviated in this
article as follows: African swine fever virus, ASFV; Amsacta
moorei entomopoxvirus, AmEPV; canarypox virus, CaPV;
chordopoxvirus, ChPV; cowpox virus, CPV; ectromelia virus, ECT;
entomopoxvirus, EPV; fowlpox virus, FPV; Heliothis armigera
entomopoxvirus, HaEPV; lumpy skin disease virus, LSV; Lymantria
dispar nuclear polyhedrosis virus, LdNPV; molluscum contagiosum
virus, MCV; myxoma virus, MYX; orf virus, OV; Paramecium bursaria chlorella virus, PBCV; rabbit fibroma virus, RFV;
rabbitpox virus, RPV; reticuloendotheliosis virus, REV; swinepox virus, SPV; tanapoxvirus, TPV; vaccinia virus, VV; and variola virus, VAR.
Nucleotide and protein sequence databases.
Accession numbers
presented are from the GenBank, SwissProt, or PIR database unless
otherwise noted.
Nucleotide sequence accession number.
The FPV genome
sequence has been deposited in GenBank under accession no. AF198100.
Organization of the FPV genome.
The FPV genome was assembled
into a contiguous sequence of 288,539 bp, which is slightly smaller in
size than previous estimates of 299 to 309 kbp for low-passage-number
FPV field strains (45, 115). Because the hairpin loops were
not sequenced, the left-most nucleotide of the assembled sequence was
arbitrarily designated base 1. The nucleotide composition is 69% A+T
and is uniformly distributed over the entire length of the FPV genome.
Six small regions (102 to 315 bp in length) with higher C+G content
(50%) are located in the terminal genomic regions (nucleotides
3219 to 5618 and 28222 to 285321). The total composition of all FPV ORFs reflects a bias for residues with A- and T-rich codons. Ile, Leu,
Lys, Asn, Tyr, and Phe constitute 45% of all encoded amino acids.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Genome of Fowlpox Virus
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
nerve growth
factors, transforming growth factor
, interleukin-18-binding protein, semaphorin, and five serine proteinase inhibitors (serpins). Other potential FPV host range proteins included homologues of those
involved in apoptosis (e.g., Bcl-2 protein), cell growth (e.g.,
epidermal growth factor domain protein), tissue tropism (e.g., ankyrin
repeat-containing gene family, N1R/p28 gene family, and a T10
homologue), and avian host range (e.g., a protein present in both fowl
adenovirus and Marek's disease virus). The presence of homologues of
genes encoding proteins involved in steroid biogenesis (e.g.,
hydroxysteroid dehydrogenase), antioxidant functions (e.g., glutathione
peroxidase), vesicle trafficking (e.g., two
-type soluble NSF
attachment proteins), and other, unknown conserved cellular processes
(e.g., Hal3 domain protein and GSN1/SUR4) suggests that
significant modification of host cell function occurs upon viral
infection. The presence of a cyclobutane pyrimidine dimer photolyase
homologue in FPV suggests the presence of a photoreactivation DNA
repair pathway. This diverse complement of genes with likely host range
functions in FPV suggests significant viral adaptation to the avian host.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
3',
Inc., Boulder, Colo.). DNA templates were sequenced from both ends with
M13 forward and reverse primers, using dideoxy chain terminator
sequencing chemistries (135) and an Applied Biosystems (ABI)
PRISM 377 automated DNA sequencer (Perkin-Elmer, Foster City, Calif.).
ABI sequence software (version 3.3) was used for lane tracking and
trace extraction. Chromatogram traces were base called with Phred
(64), which also produced a quality file containing a
predicted probability of error at each base position. The sequences
were assembled with Phrap (63), with the quality files and
default settings being used to produce a consensus sequence, with some
subsequent manual editing being performed by the Consed sequence editor
(72). An identical sequence was assembled with the TIGR
assembler, using quality files and clone length constraints
(160). Gap closure was achieved by primer walking of
gap-spanning clones and sequencing of PCR products. The final DNA
consensus sequence represented on average sixfold redundancy at each
base position.
![]()
RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

View larger version (43K):
[in a new window]
FIG. 1.
Linear map of the FPV genome. ORFs are numbered from
left to right based on the position of the methionine initiation codon.
ORFs transcribed to the right are located above horizontal lines; ORFs
transcribed to the left are below. VV homologues are indicated with red
italicized numbers. Genes with similar functions and members of gene
families are colored according to the figure key. ITRs are represented
as gray bars below the ORF map. Boxed regions 1 to 3 indicate novel
coding regions at junction sites of major genome rearrangements, and
they correspond to similarly numbered regions shown in Fig. 4.
TABLE 1.
FPV ORFs
ITRs. The FPV genome contains identical ITRs of 9,520 nucleotides at both termini (Fig. 1). Within each ITR, a 1.7-kbp region contains 42 copies of a 31- to 32-bp tandem repeat (70 to 95% identical) between nucleotides 198 and 1835 as well as between nucleotides 286703 to 288340. Sizing of seven cloned fragments spanning this tandem-repeat region produced specific size classes of 1.7, 2.4, 3.3, 5.1, and 5.8 kbp in length, indicative of length polymorphism. Therefore, individual FPV genomes could be at least 8 kbp longer than the genomic sequence assembled here. Each ITR also contains 10 ORFs. These ITR sequence data are consistent with previous descriptions of FPV ITR regions (36, 166).
Gene expression regulatory elements. FPV ORFs contain typical poxvirus promoter sequences upstream of their translation initiation codons. Sequences with similarity to the VV early-promoter consensus sequence (AAAAATGAAAAAAAA) have previously been noted in the 5' untranslated regions of known and predicted FPV early genes (90, 91, 191). Fifty-six FPV ORFs contain putative early promoters (Table 1). Of these, 22 contain a poxvirus early transcriptional stop sequence (TTTTTXT, where X is any nucleotide) near the translational stop codon (50 bases upstream to 100 bases downstream) and lack the early stop sequence elsewhere in the ORF (189). As seen in other poxviruses, many genes with potential early promoters are members of gene families and/or putative host range genes (Table 1). Three of five homologues of VV intermediate genes (FPV088, FPV126, and FPV165) contain the VV intermediate-promoter sequence (AAAXAAX11-13TAAA) (10, 11, 118), and one (FPV049) contains a single-base substitution (AAAXAG). A total of 55 putative late FPV ORFs, including many of the conserved virion-associated poxvirus genes (Table 1), contain the VV late-promoter sequence (TAAATG) at the ATG codon (131). The TAAATG late promoter has been previously described to be located upstream of FPV late genes (17, 91, 163, 191), and it is known that early-late and late promoters can be exchanged between FPV and VV with no loss of temporal specificity (27).
Transcription and mRNA biogenesis. FPV contains 26 genes involved in poxvirus transcriptional processes (Table 1). These include RNA polymerase subunits; mRNA transcription initiation, elongation, and termination factors; and the enzymes that direct posttranscriptional processing of viral mRNA (118). FPV RNA polymerase subunits include homologues of VV RPO147 (FPV137), RPO132 (FPV189), RAP94 (FPV141), RPO35 (FPV193), RPO30 (FPV100), RPO22 (FPV135), RPO19 (FPV169), RPO18 (FPV056), and RPO7 (FPV118). Homologues of all previously described early (E), intermediate (I), and late (L) poxvirus transcription factors (TFs) are found in FPV, including the following: VETFS (FPV057), VETFL (FPV171), VITF-3 (FPV172 and FPV188), VLTF-1 (FPV126), VLTF-2 (FPV049), VLTF-3 (FPV165), and VLTF-4 (FPV142) (87, 191). FPV079 and FPV183 encode elongation factors for late transcription (VV G2R and A18R) (22, 44, 186). Both transcriptional terminator NPH-1 (FPV052) and the RNA helicase NPH-II (FPV082) are present. FPV146 and FPV051 encode both subunits of the mRNA capping enzyme, and FPV102 and FPV134 encode both subunits of the poly(A) polymerase. FPV053 and FPV054 contain MutT-like motifs and are similar to VV D10R and D9R (85). D10R has recently been shown to be a negative regulator of viral transcription (149).
Nucleotide metabolism.
FPV contains homologues of
thymidine kinase (FPV086), dUTP pyrophosphatase (FPV038),
glutaredoxin (FPV077), two deoxycytidine kinases (dCKs; FPV059 and
FPV151), and a putative DNase II (FPV032) (Table 1). Genes
encoding dCK and DNase II are unique to FPV and have been previously
described (86, 93). Interestingly, sequencing of the
complete genome has revealed a second dCK gene (FPV151). These two FPV
dCK genes are 42% identical to each other and exhibit 32% amino acid
identity to cellular dCK (Table 1). The DNase II homologue, FPV032, is
truncated compared to the previously described FPV gene, FPCEL-1
(93). FPV032 represents the largest subunit (
2) of
cellular DNase II and includes the conserved histidine at the potential
active site (99, 174). The function of this gene in the
viral replication cycle is unknown; however, FPCEL-1 is not essential
for viral growth in vitro (93). Cellular DNase II is thought
to function in DNA catabolism during apoptosis (89, 168).
FPV lacks other known poxvirus genes thought to be involved in
nucleotide metabolism, including thymidylate kinase, thymidylate synthase, ribonucleotide reductase, guanylate kinase, and thioredoxin. This specific complement of nucleotide metabolism genes in FPV suggests that they have significance for cell and/or tissue tropism.
DNA replication and repair. FPV contains homologues of ChPV genes involved in DNA replication and repair (118) (Table 1). These include a DNA ligase (FPV043), ATP-GTP binding protein (FPV058), uracil DNA glycosylase (FPV062), DNA polymerase (FPV094) (19), DNA topoisomerase (FPV143), processivity factor (FPV185), and replication-essential protein kinase (FPV212).
Interestingly, FPV158 is a homologue of class II cyclobutane pyrimidine dimer (CPD) photolyases. Although the gene has been previously described in the Entomopoxvirinae (1), this is the first description of a photolyase in a ChPV. FPV158 is most similar to marsupial photolyase (56% identity over 462 amino acids) (188) and is slightly less similar to Melanoplus sanguinipes entomopoxvirus (EPV) photolyase (54% identity over 448 amino acids) (1). Both class II photolyase Prosite signatures (PS01083 and PS01084) are present with a single conservative substitution at residue 302. Although the function of this FPV gene is unknown, CPD photolyase is a photoreactive enzyme that efficiently repairs UV-induced CPD lesions in DNA, using visible light as an energy source (75). Since EPVs have insect hosts and FPV is mechanically vectored by insects (48), the presence of a photolyase gene in both viral genomes is suggestive of a relationship between a viral phase in insects and/or the environment and the need for this type of virus-encoded DNA repair.Protein modification. FPV contains at least six genes with putative protein modification functions (Table 1). The homologues encoded include three serine/threonine protein kinases (PKs) (FPV111, FPV212, and FPV226), one tyrosine PK (FPV203), a tyrosine/serine protein phosphatase (FPV138), and a metalloprotease (FPV081). FPV212 and FPV226 are similar to the serine/threonine PKs B1R and B12R of VV. FPV111 is similar to VV F10L, a serine/threonine PK essential for phosphorylation of virus proteins during virion assembly (14, 54). FPV203 shows similarity to the product of a tyrosine PK-like ORF found in rabbit fibroma virus (RFV) (109); however, neither of these poxvirus proteins contains the critical Asp residue at the predicted active site (Prosite PS00109). FPV138 is a homologue of the VV H1L tyrosine/serine protein phosphatase, which is involved in VV assembly (54). FPV081 is a homologue of the VV protease G1L. This protein contains the characteristic amino-terminal His-XX-Glu-His inverted metalloprotease motif, and it may function in viral protein processing and virion morphogenesis (178).
Structural proteins. FPV encodes homologues of at least 31 known VV structural proteins, and the majority of them are associated with the intracellular mature virus particle (IMV) (Table 1). FPV homologues of VV core proteins include FPV069 (D3R), FPV083 (I7L), FPV090 (I1L), FPV103 (F17R), FPV120 (G7L), FPV131 (L4R), FPV148 (D2L), FPV167 (A3L), FPV168 (A4L), FPV174 (A10L), and FPV176 (A12L) (15, 25). FPV homologues of VV IMV membrane-associated proteins include FPV050 (D13L), FPV085 (I5L), FPV128 (L1R), FPV140 (H3L), FPV178 (A13L), FPV179 (A14L), and FPV182 (A17L). FPV lacks homologues of VV IMV membrane proteins A27L, which is required for extracellular enveloped virion (EEV) envelopment and egress and for heparan sulfate binding (41, 130), and D8L, a cell surface binding protein (103). FPV structural proteins FPV120, FPV131, FPV167, FPV174, FPV176, and FPV182, like their VV homologues, contain the conserved AG proteolytic cleavage sites, which suggests that aspects of structural protein processing are conserved in FPV (173). FPV197 is the homologue of VV ATP-GTP binding protein A32L, which likely functions in virion assembly and DNA packaging (38).
FPV contains three genes that encode proteins potentially associated with EEVs (118, 123). FPV108, FPV109, and FPV198 are similar to VV F13L, F12L, and A34R, respectively (35). Missing from FPV are obvious homologues of VV EEV genes B5R, A33R, A36R, and A56R. EEV membrane proteins are involved with EEV formation, release, and infectivity (23, 111, 181). Since these functions may be associated with aspects of host range, the lack of well-conserved homologues of these genes in FPV is not surprising. Homologues of five genes representing two conserved poxvirus gene families with putative structural functions are present in FPV. The genes encoding FPV112 and FPV128, homologues of VV F9L and L1R, respectively, comprise one gene family (142). The genes encoding FPV127, FPV136, and FPV181, homologues of VV G9R, J5L, and A16L, respectively, comprise a second, small gene family. G9R and A16L proteins are myristylated and potentially soluble (105), and J5L is thought to be an essential gene (190). Invariant cysteine residues and putative transmembrane domains unique to each family are conserved in these FPV ORFs (142). FPV190 and FPV191 are homologues of poxvirus A-type inclusion (ATI) proteins (Table 1), insoluble proteins that constitute the protein matrix of ATIs. Cytoplasmic ATIs are thought to protect mature virions from environmental insults, and they may be of significance for FPV transmission in nature (40, 82, 128, 133).Host-related functions. FPV contains a significant number of putative host range genes that exhibit similarity to cellular genes and to other known poxvirus genes. This diverse complement of host range genes, some of which are novel, is suggestive of significant adaptation to the avian host. These genes may function in host immune evasion, immune modulation, and aspects of cell and/or tissue tropism or perform other cellular functions. Most of these genes are found in terminal regions of the FPV genome, although several groupings of them are more centrally located.
Immune evasion functions.
FPV080 is a homologue of the
eukaryotic transforming growth factor
(TGF-
) (Table 1; Fig.
2A). To our knowledge, this is the first
TGF-
gene found in a virus genome. Similarities to eukaryotic
TGF-
include the 112-amino-acid peptide region of the active
protein, Prosite signature PS00250 (with one mismatch), and cysteines
necessary for intra- and interchain disulfide bond formation. TGF-
is a multifunctional peptide that both stimulates connective tissue
cell growth and differentiation, particularly during neovascularization
and wound healing, and suppresses proliferation of most other cell
types (58). TGF-
also exhibits a range of immunomodulatory effects, including suppression of cellular and humoral immune mechanisms, specifically generation and/or activity of
cytotoxic T lymphocytes, natural killer (NK) cells, and
lymphokine-activated killer cells, generation and/or activity of
lymphokines (interleukin-1 [IL-1], IL-6, tumor necrosis factor, and
IL-2); and production of polyclonal antibodies (58).
Chemoattractant and proinflammatory properties have also been
associated with TGF-
(58). A role for FPV080 in
suppression of the host immune response and/or cell growth and
differentiation is likely.
|
nerve growth factor
(
-NGF) (Table 1; Fig. 2B). This is the first example of a virus
encoding
-NGF-like genes. Both FPV proteins contain the six cysteine
residues involved in intrachain disulfide bonding and the Prosite
-NGF family signature (PS00248) (Fig. 2B).
-NGF, a member of the
neurotrophin protein family, stimulates neuronal survival, division,
and differentiation and promotes survival of memory B lymphocytes and
mast cells (30, 97, 167). Recently,
-NGF has been shown
to be an autocrine survival factor for human immunodeficiency virus
type 1-infected macrophages (68). An FPV-encoded
-NGF may be involved in promoting infected-cell survival. In
addition,
-NGF has proinflammatory and immunomodulatory
effects (5).
-NGF, which is produced by fibroblasts and
keratinocytes in response to injury, induces differentiation,
activation, and degranulation of mast cells and modifies expression of
mast cell-derived immunoregulatory mediators and cytokines (34,
104, 138, 176, 177, 183). Conceivably, a virus-encoded
-NGF
antagonist could have a role in inhibiting antiviral immune responses
in FPV-infected skin and respiratory tract. Given that mast cells are
initiators and amplifiers of innate immune responses, the presence of
-NGF homologues in FPV suggests that interference with early innate immune responses may be important for viral infection.
FPV060, FPV061, FPV116, and FPV121 exhibit similarity to the CC class
of small soluble chemokines found in vertebrates (Table 1). The FPV
genes contain the conserved pattern of four cysteines which are
necessary for disulfide bond formation (Prosite PS00472), as well as
other conserved residues (Fig. 2C). The FPV genes are similar in size
(120 to 181 amino acids) to other known CC chemokines. Three of the
products contain potential signal sequences at the N terminus,
indicating that they may be secreted proteins. In general, CC
chemokines attract T lymphocytes and NK cells to sites of infection
(113). Other ChPVs modulate CC chemokine activity by
secreting novel proteins that specifically bind CC chemokines and
inhibit their effects in vitro and in vivo. These inhibitors are
widespread among mammalian poxviruses, including VV, variola virus
(VAR), cowpox virus (CPV), RFV, myxoma virus (MYX), and rabbitpox virus
but is notably absent from FPV (4, 73, 94, 151). In
molluscum contagiosum virus (MCV), a CC chemokine-like protein, MC148R,
functions as a broad-spectrum CC and CXC chemokine antagonist
(49). FPV's large repertoire of CC chemokine homologues functioning as antagonists could result in broad-range inhibition of
normal CC chemokine function during host antiviral immune responses. Alternatively, as is the case for the viral macrophage-inhibitory protein 1 chemokine encoded by human herpesvirus 8, FPV chemokine homologues may function as agonists to modify normal host immune responses (47, 61).
FPV contains three genes encoding proteins with homology to
G-protein-coupled receptors (Table 1). FPV021 and FPV027 are most
similar to a monkey chemokine receptor protein (GPR1), while FPV206 is
most closely related to the human Epstein-Barr virus-induced G-protein-coupled receptor (21). The highest level of amino acid similarity to cellular genes occurs at the seven transmembrane domains, the first cytoplasmic domain, and the second extracellular domain. The conserved acidic amino acid-Arg-aromatic amino acid triplets in the amino-terminal portion of the second aromatic loop, which have been implicated in the interaction with G
proteins, are conserved in FPV021 and conservatively substituted in
FPV027 and FPV206 (8). As with other G-protein-coupled
receptors, the FPV proteins contain potential glycosylation
sites at their carboxyl termini. G-protein-coupled receptors are
integral membrane proteins that transduce extracellular signals to the
intracellular environment through activation of the
phosphatidylinositol-calcium second-messenger system (139).
These receptors have been identified in the capripoxviruses and in
swinepox virus, where their function is not known (37, 107).
However, G-protein-coupled receptors encoded by several herpesvirus
genomes are able to bind chemokines and invoke signal transduction
responses that affect viral replication and pathogenesis in the host
(2, 7, 13, 67).
FPV073 exhibits similarity to mammalian and ChPV IL-18-binding protein
and contains potential N-glycosylation sites and a signal peptide
(Table 1) (142, 184). Cellular and MCV IL-18bp homologues
have been found to inhibit IL-18-dependent gamma interferon production
(3, 185). IL-18 is a multifunctional proinflammatory cytokine of the IL-1 family that induces gamma interferon production, Th-1 responses, and NK cell activity, and it is important for effective
host responses to VV infection in mice (50, 56, 79, 114, 161,
162). An anti-inflammatory function for FPV073 is likely.
FPV047 most closely resembles mammalian K/L-type semaphorins and the
alcelaphine herpesvirus semaphorin homologue (accession no. U18243)
(33% identity over 597 amino acids) (Table 1). Like the K/L-type
semaphorin and alcelaphine herpesvirus semaphorin, FPV064 contains a
potential amino-terminal signal sequence, a large semaphorin K/L
domain, an immunoglobulin (Ig) domain, and a hydrophobic carboxyl
terminus (62, 95). VV also encodes a K/L-like semaphorin
homologue (A39R); however, the semaphorin domain is truncated and the
Ig domain is absent (84). Semaphorins are a large family of
secreted and membrane-associated proteins that act as axon guidance
molecules during embryonic development and may affect organogenesis,
vascularization, and angiogenesis (154). In addition, the
CD100 semaphorin protein found on the surface of T lymphocytes
functions in cell activation (52). The secreted VV A39R
protein binds a plexin-like receptor found on lymphocytes and induces
cytokine production and ICAM up-regulation in monocytes
(43). The FPV semaphorin homologue may have a similar immunomodulatory function.
FPV contains eight ORFs (FPV001, FPV003, FPV008, FPV235,
FPV239, FPV253, FPV258, and FPV260) with homology to C-type lectins NKG2 and CD94 proteins present on NK cells and CD69 protein present on
lymphocytes (Table 1). Similar proteins have been described in
poxviruses (VV and CPV) and African swine fever virus (ASFV) (122,
145, 179). Although the functions of these viral proteins are
unknown, the VV C-type lectin protein, A40R, localizes to infected cell
plasma membranes (179). C-type lectin cellular NK cell
receptors bind class I major histocompatibility complex antigens and
promote or inhibit immune activity through intracellular signaling
pathways (66, 132, 175). It is conceivable that the
expression of these proteins in FPV-infected cells interferes with
normal immune surveillance or host responses.
FPV encodes five homologues of serine proteinase inhibitors
(serpins) (FPV010, FPV040, FPV044, FPV204, and FPV251) (Table 1).
All contain the serpin Prosite signature (PS00284) and exhibit 21 to
29% amino acid identity to each other. Serpin genes have been
found in most ChPVs (rabbitpox virus, RFV, VV, VAR, CPV, MYX,
and ectromelia virus [ECT]), where they perform host range functions
involving anti-inflammatory activity and/or regulation of cellular
apoptosis in specific cells through inhibition of IL-1
-converting
enzyme, the cytotoxic-T-lymphocyte-derived protease granzyme B, and
other caspases within the apoptosis-regulatory cascade
(172).
Other host range functions.
The gene encoding FPV039 is the
first reported poxvirus member of the Bcl-2 gene family.
FPV039 resembles MCL1, a protein induced during monocyte/macrophage
differentiation in myeloid leukemia cell lines, and BFL1 (29% identity
over 134 amino acids), an antiapoptosis protein expressed specifically
in the bone marrow, spleen, and thymus (88, 100) (Table 1;
Fig. 3A). FPV039 contains one BH1 domain
and one modified BH2 domain (Prosites PS01080 and PS01258) but lacks
additional BH3 and BH4 domains. As with other viral Bcl-2 homologues,
FPV039 may prevent a cellular apoptotic response to viral infection
(12).
|
Cellular functions. FPV114 shares a 180-amino-acid conserved domain with proteins found in plants (accession no. U80192), yeast (accession no. P36024 and X88900), roundworms (accession no. Z81069), and bacteria (accession no. P24285, P30197, Q04810, and D90910). FPV114 is most closely related to the yeast Hal3 and SIS2 genes and a putative Hal3 homologue from the plant Arabidopsis thaliana (Table 1). These proteins function as inhibitory subunits of cellular protein phosphatases, and they promote salt tolerance and affect growth (53). FPV114, roundworm, and bacterial homologues lack the amino- and carboxyl-terminal domains found in the yeast protein. Bacterial homologues function in DNA/pantothenate and lantibiotic metabolism (39, 92). The wide phylogenetic distribution of FPV114 homologues suggests that their function is highly conserved.
FPV048 encodes a 261-amino-acid protein that is similar to the members of the GNS1/SUR4 family of integral membrane proteins (Table 1). Similarities to the GNS1/SUR4 gene family include a defined motif (BLOCKs database signature BL01188) and a conserved protein structure consisting of an N-terminal region with two transmembrane domains, a central hydrophilic loop, a C-terminal region with one to three transmembrane domains, and the Prosite family signature (PS01188). The yeast GNS1 and SUR4 genes function in glucose metabolism, and they are suspected to have pleiotrophic functions in the cellular response to nutrient availability (60, 69, 129). FPV011 and FPV033 are similar to the eukaryotic
-type soluble NSF
attachment protein (
-SNAP) (Table 1). FPV033 has been previously
described, but this is the first report of a second FPV
-SNAP
homologue (93). FPV011 and FPV033 are similar in size (278 and 267 amino acids long, respectively) and exhibit 34% amino acid
identity to each other over 249 amino acids.
-SNAPs are involved in
vesicular trafficking, mediating intracellular membrane
fusion by recruiting soluble NSF to membrane receptors (158).
-SNAPs and their yeast homologues (Sec17)
are required for vesicular transport through the Golgi complex and for
exocytosis (42, 117). The fact that FPV033 is not essential
for growth in vitro suggests that it has a host range function
(93).
FPV093 is the homologue of VV E10R, a protein that is conserved in many
cytoplasmic DNA viruses and eukaryotes and contains a pattern of
cysteine residues typical of glutaredoxin and thioredoxin redox-active
centers (78). The homologue of this protein in ASFV, 9GL,
has recently been shown to be involved in virion maturation and viral
growth in swine macrophages (98).
FPV030 exhibits homology to human PC-1, which has alkaline
phosphodiesterase and nucleotide pyrophosphatase activities and has
been previously found in FPV (33, 93). The function of this
conserved but nonessential FPV gene is unknown; however, it has been
suggested that it may provide an external source of nucleotides or
regulate signal transduction (93).
FPV046 encodes a homologue of 3-
-hydroxysteroid dehydrogenase
(3
HSDH), previously described in FPV and other poxviruses (VV and
MCV) (Table 1) (116, 142, 150). In VV, 3
HSDH has steroidogenic activity in vitro and is involved in viral virulence in
vivo (116). Cellular 3
HSDH catalyzes the oxidative
conversion of both
(5)-ene-3-
-hydroxysteroid and ketosteroids,
performing a crucial role in the biosynthesis of all classes of steroid hormones.
Two unrelated FPV ORFs, FPV029 and FPV071, have striking similarity to
genes present in a diverse phylogenetic range of organisms (Table 1).
FPV029 is similar to proteins of unknown function from yeast
(accession no. P34222), bacteria (accession no. U67463 and AE000927), a
roundworm (accession no. AF067936), a plant (accession no. AL031804),
the fruit fly (accession no. AE0015722), and humans (accession no.
AF151905). All of these proteins show several conserved domains, and
the bacterial genes and the FPV037 ORF have similar lengths. FPV071 is
similar to genes of unknown function from yeast (accession no. P40506), humans (accession no. AI391502), tomato (accession no. AI771876), and
fruit fly (accession no. AF132150).
Gene families of unknown function. FPV097, FPV098, FPV099, FPV107, FPV122, and FPV123 are homologues of VAR B22R (Table 1). B22R homologues are also present in CPV, ECT, and MCV but are absent from VV (6, 71). FPV gene family members exhibit 34 to 52% amino acid identity to each other and 32 to 36% identity to the other poxvirus homologues, with the highest level of similarity being in the carboxyl-terminal regions. Several features make these FPV B22R homologues notable. They represent the largest genes in FPV (1,766 to 1,949 amino acids), and they comprise 12% of the viral genome. FPV contains multiple B22R homologues, while other poxviruses either contain a single copy of the gene or lack it (71, 108, 142). FPV B22R homologues are present in a central genomic region, while orthopoxvirus homologues are located in the terminal regions of their respective genomes (Fig. 1) (71, 108). Although no function has yet been assigned to any of these ORFs, it has been suggested that they are type II membrane proteins (108, 145).
FPV017, FPV055, FPV125, FPV199, and FPV200 have similarity to V-type Ig domains of diverse proteins (Table 1). All five proteins contain conserved Ig domain cysteines and surrounding residues. FPV017 and FPV199 are notably similar to each other (25% amino acid identity), as are FPV055 and FPV125 (37% identity over 270 amino acids). Cellular members of the Ig superfamily include secreted and membrane-bound receptors and cell adhesion proteins (180). Ig domain-containing proteins, including hemagglutinin, cytokine receptor, and HLA antigen homologues, are present in other poxviruses (141, 142, 147, 152). FPV067, FPV087, FPV147, FPV152, FPV156, and FPV209 comprise the His-X-X-Thr motif gene family (HT motif). These genes exhibit 18 to 34% identity over 69 to 102 amino acids and contain the HT motif at residues 19 to 33 or 51 to 65. FPV147, FPV152, and FPV209 also have HX4-5T motifs upstream of the primary HT motif. The HT family ORFs have no significant similarity to other sequences in the database. FPV006 and FPV255 are 35% identical to FPV020 over 283 amino acids. All three FPV ORFs are similar to VV C10L and C4L and homologues present in CPV and VAR (Table 1). Like their orthopoxvirus homologues, these FPV ORFs are located in the terminal genomic regions. Although their function has not been determined, C10L and C4L are dispensable for virus growth in cell culture (126).Relationship of FPV to other ChPVs.
FPV resembles other ChPVs
in overall genome structure and composition (the presence of a central
conserved core of genes, ITRs, and large numbers of homologues).
However, compared to those of other ChPVs, the genome of FPV exhibits
large-scale genomic rearrangement, more extensive gene
families, and the presence of novel host range genes. Genomic
comparisons of FPV and VV have shown major rearrangement of blocks of
genes (115). Analysis of the complete FPV genomic
sequence reveals that FPV contains at least two major genomic
rearrangements in the conserved colinear core of genes present in VV,
VAR, and MCV (71, 108, 142) (Fig. 4). A 12-kbp FPV genomic region
containing ORFs FPV049 to FPV058 (comparable to VV A1L to D5R) is
inverted and translocated toward the left end of the genome relative to
VV. A 56-kbp FPV genomic region containing ORFs FPV077 to
FPV112 (comparable to VV G4L to F9L) is inverted relative to VV. At the
junction sites of these major rearrangements there are novel coding
regions of 5 to 17.5 kbp (see boxed areas 1 to 3 in Fig. 1 and regions
1 to 3 in Fig. 4). Genes within these junction regions are
predominantly homologues of cellular genes and/or are members of gene
families. This clustering of cellular homologues and gene families in
central genomic locations has not been previously observed in
the subfamily Chordopoxvirinae, in which these types of
genes are generally found in terminal variable regions of the genome
(71, 106, 141). This observation suggests that blocks of
genes may have translocated from terminal variable regions of the
genome to central regions during large-scale rearrangements of FPV. FPV
genome colinearity with genomes of other ChPVs is also interrupted at
multiple sites by insertions or deletions of individual genes and
multiple copies of B22R gene family members (Fig. 1 and 4 and Table 1).
|
-NGF,
-SNAP, and dCK). It has been suggested that the size of the
ankyrin repeat multigene family may affect poxvirus host range
(145). The large number of FPV multigene family members,
together with the wide avian host range of FPV, provides support for
the role of gene families in host range (169).
Conclusions. FPV genome analysis provides basic knowledge of viral functions, including mRNA biogenesis, DNA replication and repair, nucleotide metabolism, protein processing, manipulation of cellular responses, viral virulence, and host range, which underlie FPV interactions with its avian host and the environment. An improved understanding of these interactions will permit the engineering of novel vaccine viruses and expression vectors with enhanced efficacy and greater versatility. Additionally, the identification and characterization of FPV virulence and host range genes will contribute novel concepts to our overall understanding of pathogen-host interactions, information that is likely to have a broad impact on future strategies for controlling avian infectious diseases in general.
| |
ACKNOWLEDGMENTS |
|---|
We thank Scott Taylor for providing the NVSL challenge strain of FPV; A. Ciupryk and G. Smoliga for excellent technical assistance; and W. H. Martinez, F. P. Horn, and R. G. Breeze for interest and encouragement.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Plum Island Animal Disease Center, P.O. Box 848, Greenport, NY 11944-0848. Phone: (516) 323-3330. Fax: (516) 323-2507. E-mail: drock{at}cshore.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Afonso, C. L.,
E. R. Tulman,
Z. Lu,
E. Oma,
G. F. Kutish, and D. L. Rock.
1999.
The genome of Melanoplus sanguinipes entomopoxvirus.
J. Virol.
73:533-552 |
| 2. |
Ahuja, S. K., and P. M. Murphy.
1993.
Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri.
J. Biol. Chem.
268:20691-20694 |
| 3. | Aizawa, Y., K. Akita, M. Taniai, K. Torigoe, T. Mori, Y. Nishida, S. Ushio, Y. Nukada, T. Tanimoto, H. Ikegami, M. Ikeda, and M. Kurimoto. 1999. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 445:338-342[CrossRef][Medline]. |
| 4. |
Alcami, A.,
J. A. Symons,
P. D. Collins,
T. J. Williams, and G. L. Smith.
1998.
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
J. Immunol.
160:624-633 |
| 5. | Aloe, L., M. D. Simone, and F. Properzi. 1999. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc. Res. Tech. 45:285-291[CrossRef][Medline]. |
| 6. | Antoine, G., F. Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396[CrossRef][Medline]. |
| 7. | Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350[CrossRef][Medline]. |
| 8. | Attwood, T. K., E. E. Eliopoulos, and J. B. C. Findlay. 1991. Multiple sequence alignment of protein families showing low sequence homology: a methodological approach using database pattern-matching discriminators for G-protein-linked receptors. Gene 98:153-159[CrossRef][Medline]. |
| 9. | Back, A., R. A. Soncini, O. Ruthes, S. Madureira, Jr., and R. Flores. 1995. An atypical fowl pox outbreak in broilers in southern Brazil. Avian Dis. 39:902-906[CrossRef][Medline]. |
| 10. |
Baldick, C. J., Jr.,
J. G. Keck, and B. Moss.
1992.
Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.
J. Virol.
66:4710-4719 |
| 11. |
Baldick, C. J., Jr., and B. Moss.
1993.
Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
J. Virol.
67:3515-3527 |
| 12. | Barry, M., and G. McFadden. 1998. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 10:422-430[CrossRef][Medline]. |
| 13. |
Beisser, P. S.,
G. Grauls,
C. A. Bruggeman, and C. Vink.
1999.
Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain.
J. Virol.
73:7218-7230 |
| 14. |
Betakova, T.,
E. J. Wolffe, and B. Moss.
1999.
Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.
J. Virol.
73:3534-3543 |
| 15. |
Binns, M.,
C. Mason, and M. Boursnell.
1990.
A 39,000 Mr immunodominant protein of fowlpox virus contains multiple copies of a 12 amino acid repeat sequence.
J. Gen. Virol.
71:2883-2888 |
| 16. | Binns, M. M., M. E. G. Boursnell, and M. A. Skinner. 1992. Gene translocations in poxviruses: the fowlpox virus thymidine kinase gene is flanked by 15 bp direct repeats and occupies the locus which in vaccinia virus is occupied by the ribonucleotide reductase large subunit gene. Virus Res. 24:161-172[CrossRef][Medline]. |
| 17. | Binns, M. M., M. E. G. Boursnell, F. M. Tomley, and J. Campbell. 1989. Analysis of the fowlpoxvirus gene encoding the 4b core polypeptide and demonstration that it possesses efficient promoter sequences. Virology 170:288-291[CrossRef][Medline]. |
| 18. |
Binns, M. M.,
B. S. Britton,
C. Mason, and M. E. Boursnell.
1990.
Analysis of the fowlpox virus genome region corresponding to the vaccinia virus D6 to A1 region: location of, and variation in, non-essential genes in poxviruses.
J. Gen. Virol.
71:2873-2881 |
| 19. |
Binns, M. M.,
L. Stenzler,
F. M. Tomley,
J. Campbell, and M. E. Boursnell.
1987.
Identification by a random sequencing strategy of the fowlpoxvirus DNA polymerase gene, its nucleotide sequence and comparison with other viral DNA polymerases.
Nucleic Acids Res.
15:6563-6573 |
| 20. |
Binns, M. M.,
F. M. Tomley,
J. Campbell, and M. E. G. Boursnell.
1988.
Comparison of a conserved region in fowlpox virus and vaccinia virus genomes and the translocation of the fowlpox virus thymidine kinase gene.
J. Gen. Virol.
69:1275-1283 |
| 21. |
Birkenbach, M.,
K. Josefsen,
R. Yalamanchili,
G. Lenoir, and E. Kieff.
1993.
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.
J. Virol.
67:2209-2220 |
| 22. | Black, E. P., N. Moussatche, and R. C. Condit. 1998. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 245:313-322[CrossRef][Medline]. |
| 23. |
Blasco, R., and B. Moss.
1991.
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein.
J. Virol.
65:5910-5920 |
| 24. | Blaxland, J. D. 1976. Atypical fowl pox in chickens. Vet. Rec. 99:222[Medline]. |
| 25. |
Boulanger, D.,
P. Green,
T. Smith,
C.-P. Czerny, and M. A. Skinner.
1998.
The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic.
J. Virol.
72:170-179 |
| 26. | Boyle, D. B. 1994. Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors. Reprod. Fertil. Dev. 6:393-400[CrossRef][Medline]. |
| 27. | Boyle, D. B. 1992. Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants. Virus Genes 6:281-290[CrossRef][Medline]. |
| 28. | Boyle, D. B., and H. G. Heine. 1993. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell Biol. 71:391-397. |
| 29. | Boyle, D. B., A. D. Pye, and B. E. H. Coupar. 1997. Comparison of field and vaccine strains of Australian fowlpox viruses. Arch. Virol. 142:737-748[CrossRef][Medline]. |
| 30. | Bradshaw, R. A., T. L. Blundell, R. Lapatto, N. Q. McDonald, and J. Murray-Rust. 1993. Nerve growth factor revisited. Trends Biochem. Sci. 18:48-52[CrossRef][Medline]. |
| 31. | Brick, D. J., R. D. Burke, L. Schiff, and C. Upton. 1998. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis. Virology 249:42-51[CrossRef][Medline]. |
| 32. | Brunovskis, P., and L. F. Velicer. 1995. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206:324-338[CrossRef][Medline]. |
| 33. |
Buckley, M. F.,
K. A. Loveland,
W. J. McKinstry,
O. M. Garson, and J. W. Goding.
1990.
Plasma cell membrane glycoprotein PC-1.
J. Biol. Chem.
265:17506-17511 |
| 34. |
Bullock, E. D., and E. M. Johnson, Jr.
1996.
Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion.
J. Biol. Chem.
271:27500-27508 |
| 35. | Calvert, J. G., R. Ogawa, N. Yanagida, and K. Nazerian. 1992. Identification and functional analysis of the fowlpox virus homolog of the vaccinia virus p37K major envelope antigen gene. Virology 191:783-792[CrossRef][Medline]. |
| 36. |
Campbell, J. I. A.,
M. W. Binns,
F. M. Tomley, and M. E. G. Boursnell.
1989.
Tandem repeated sequences within the terminal region of the fowlpox virus genome.
J. Gen. Virol.
70:145-154 |
| 37. | Cao, J. X., P. D. Gershon, and D. N. Black. 1995. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology 209:207-212[CrossRef][Medline]. |
| 38. |
Cassetti, M. C.,
M. Merchlinsky,
E. J. Wolffe,
A. S. Weisberg, and B. Moss.
1998.
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.
J. Virol.
72:5769-5780 |
| 39. |
Chen, N.-Y.,
S.-Q. Jiang,
D. A. Klein, and H. Paulus.
1993.
Organization and nucleotide sequence of the Bacillus subtilis diaminopimelate operon, a cluster of genes encoding the first three enzymes of diaminopimelate synthesis and dipicolinate synthase.
J. Biol. Chem.
268:9448-9465 |
| 40. | Cheville, N. F. 1966. Cytopathologic changes in fowlpox (turkey origin) inclusion body formation. Am. J. Pathol. 49:723-737[Medline]. |
| 41. |
Chung, C.-S.,
J.-C. Hsiao,
Y.-S. Chang, and W. Chang.
1998.
A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate.
J. Virol.
72:1577-1585 |
| 42. | Clary, D. O., I. C. Griff, and J. E. Rothman. 1990. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast. Cell 61:709-721[CrossRef][Medline]. |
| 43. | Comeau, M. R., R. Johnson, R. F. DuBose, M. Petersen, P. Gearing, T. VandenBos, L. Park, T. Farrah, R. M. Buller, J. I. Cohen, L. D. Strockbine, C. Rauch, and M. K. Spriggs. 1998. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8:473-482[CrossRef][Medline]. |
| 44. | Condit, R. C., Y. Xiang, and J. I. Lewis. 1996. Mutation of vaccinia virus gene G2R causes suppression of gene A18R ts mutants: implications for control of transcription. Virology 220:10-19[CrossRef][Medline]. |
| 45. | Coupar, B. E. H., T. Teo, and D. B. Boyle. 1990. Restriction endonuclease mapping of the fowlpox virus genome. Virology 179:159-167[CrossRef][Medline]. |
| 46. | Cunningham, C. H. 1984. Avian pox, p. 597-609. In M. S. Hofstad, H. J. Barnes, B. W. Calnek, W. M. Reid, and H. W. Yoder, Jr. (ed.), Diseases of poultry. Iowa State University Press, Ames. |
| 47. |
Dairaghi, D. J.,
R. A. Fan,
B. E. McMaster,
M. R. Hanley, and T. J. Schall.
1999.
HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8.
J. Biol. Chem.
274:21569-21574 |
| 48. | DaMassa, A. J. 1965. The role of Culex tarsalis in the transmission of fowl pox virus. Avian Dis. 10:57-66. |
| 49. |
Damon, I.,
P. M. Murphy, and B. Moss.
1998.
Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog.
Proc. Natl. Acad. Sci. USA
95:6403-6407 |
| 50. | Dao, T., K. Ohashi, T. Kayano, M. Kurimoto, and H. Okamura. 1996. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173:230-235[CrossRef][Medline]. |
| 51. | Davison, A. J., and B. Moss. 1989. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:749-769[CrossRef][Medline]. |
| 52. | Delaire, S., A. Elhabazi, A. Bensussan, and L. Boumsell. 1998. CD100 is a leukocyte semaphorin. Cell. Mol. Life Sci. 54:1265-1276[CrossRef][Medline]. |
| 53. |
De Nadal, E.,
J. Clotet,
F. Posas,
R. Serrano,
N. Gomez, and J. Arino.
1998.
The yeast halotolerance determinant Hal3p is an inhibitory subunit of the Ppz1p Ser/Thr protein phosphatase.
Proc. Natl. Acad. Sci. USA
95:7357-7362 |
| 54. |
Derrien, M.,
A. Punjabi,
M. Khanna,
O. Grubisha, and P. Traktman.
1999.
Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase.
J. Virol.
73:7287-7296 |
| 55. | Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395. |
| 56. | Dinarello, C. A. 1999. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:11-24[CrossRef][Medline]. |
| 57. | Drillien, R., D. Spehner, D. Villeval, and J.-P. Lecocq. 1987. Similar genetic organization between a region of fowlpox virus DNA and the vaccinia virus HindIII J fragment despite divergent location of the thymidine kinase gene. Virology 160:203-209[CrossRef][Medline]. |
| 58. | Durum, S. K., and J. J. Oppenheim. 1993. Proinflammatory cytokines and immunity, p. 801-835. In W. E. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York, N.Y. |
| 59. | Eidson, C. S., P. Villegas, and S. H. Kleven. 1975. Efficacy of turkey herpesvirus vaccine when administered simultaneously with fowl pox vaccine. Poult. Sci. 54:1975-1981[Medline]. |
| 60. |
El-Sherbeini, M., and J. A. Clemas.
1995.
Cloning and characterization of GNS1: a Saccharomyces cerevisiae gene involved in synthesis of 1,3- -glucan in vitro.
J. Bacteriol.
177:3227-3234 |
| 61. |
Endres, M. J.,
C. G. Garlisi,
H. Xiao,
L. Shan, and J. A. Hedrick.
1999.
The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.
J. Exp. Med.
189:1993-1998 |
| 62. |
Ensser, A., and B. Fleckenstein.
1995.
Alcelaphine herpesvirus type 1 has a semaphorin-like gene.
J. Gen. Virol.
76:1063-1067 |
| 63. |
Ewing, B., and P. Green.
1998.
Base-calling of automated sequencer traces using Phred. II. Error probabilities.
Genome Res.
8:186-194 |
| 64. |
Ewing, B.,
L. Hillier,
M. C. Wendl, and P. Green.
1998.
Base-calling of automated sequencer traces using Phred. I. Accuracy assessment.
Genome Res.
8:175-185 |
| 65. | Fatunmbi, O. O., and W. M. Reed. 1996. Evaluation of a commercial quail pox vaccine (Bio-Pox Q) for the control of "variant" fowl poxvirus infections. Avian Dis. 40:792-797[CrossRef][Medline]. |
| 66. |
Fukuda, M.,
N. Hiraoka, and J.-C. Yeh.
1999.
C-type lectins and sialyl Lewis X oligosaccharides: versatile roles in cell-cell interaction.
J. Cell Biol.
147:467-470 |
| 67. |
Gao, J.-L., and P. M. Murphy.
1994.
Human cytomegalovirus open reading frame US28 encodes a functional chemokine receptor.
J. Biol. Chem.
269:28539-28542 |
| 68. |
Garaci, E.,
M. C. Caroleo,
L. Aloe,
S. Aquaro,
M. Piacentini,
N. Costa,
A. Amendola,
A. Micera,
R. Calio,
C. F. Perno, and R. Levi-Montalcini.
1999.
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV.
Proc. Natl. Acad. Sci. USA
96:14013-14018 |
| 69. |
Garcia-Arranz, M.,
A. M. Maldonado,
M. J. Mazon, and F. Portillo.
1994.
Transcriptional control of yeast plasma membrane H+-ATPase by glucose.
J. Biol. Chem.
269:18076-18082 |
| 70. |
Gillard, S.,
D. Spehner,
R. Drillien, and A. Kirn.
1986.
Localization and sequence of a vaccinia virus gene required for multiplication in human cells.
Proc. Natl. Acad. Sci. USA
83:5573-5577 |
| 71. | Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266[CrossRef][Medline]. |
| 72. | Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:192-202. |
| 73. | Graham, K. A., A. S. Lalani, J. L. Macen, T. L. Ness, M. Barry, L.-Y. Liu, A. Lucas, I. Clark-Lewis, R. W. Moyer, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12-24[CrossRef][Medline]. |
| 74. | Halford, S., D. I. Wilson, S. C. Daw, C. Roberts, R. Wadey, S. Kamath, A. Wickremasinghe, J. Burn, J. Goodship, and M. G. Mattei. 1993. Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome. Hum. Mol. Genet. 10:1577-1582. |
| 75. |
Hearst, J. E.
1995.
The structure of photolyase: using photon energy for DNA repair.
Science
268:1858-1859 |
| 76. | Hertig, C., B. E. H. Coupar, A. R. Gould, and D. B. Boyle. 1997. Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 235:367-376[CrossRef][Medline]. |
| 77. | Hitchner, S. B. 1981. Canary pox vaccination with live embryo-attenuated virus. Avian Dis. 25:874-881[CrossRef][Medline]. |
| 78. | Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54:237-271[CrossRef][Medline]. |
| 79. |
Hyodo, Y.,
K. Matsui,
N. Nayashi,
H. Tsutsui,
S. I. Kashiwamura,
H. Yamauchi,
K. Hiroishi,
K. Takeda,
Y.-I. Tagawa,
Y. Iwakura,
N. Kayagaki,
M. Kurimoto,
H. Okamura,
T. Hada,
H. Yagita,
S. Akira,
K. Nakanishi, and K. Higashino.
1999.
IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
J. Immunol.
162:1662-1668 |
| 80. | Ink, B. S., C. S. Gilbert, and G. I. Evan. 1995. Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes. J. Virol. 69:661-668[Abstract]. |
| 81. |
Joazeiro, C. A. P.,
S. S. Wing,
H.-K. Huang,
J. D. Leverson,
T. Hunter, and Y.-C. Liu.
1999.
The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Science
286:309-312 |
| 82. | Kato, S., and W. Cutting. 1959. A study of the inclusion bodies of rabbit myxoma and fibroma virus and a consideration of the relationship between all pox virus inclusion bodies. Stanford Med. Bull. 17:34-45[Medline]. |
| 83. |
Kent, S. J.,
A. Zhao,
S. J. Best,
J. D. Chandler,
D. B. Boyle, and I. A. Ramshaw.
1998.
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.
J. Virol.
72:10180-10188 |
| 84. | Kolodkin, A. L., D. J. Matthes, and C. S. Goodman. 1993. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75:1389-1399[CrossRef][Medline]. |
| 85. |
Koonin, E. V.
1993.
A highly conserved sequence motif defining the family of MutT-related proteins from eubacteria, eukaryotes and viruses.
Nucleic Acids Res.
21:4847 |
| 86. | Koonin, E. V., and T. G. Senkevich. 1993. Fowlpox virus encodes a protein related to human deoxycytidine kinase: further evidence for independent acquisition of genes for enzymes of nucleotide metabolism by different viruses. Virus Genes 7:289-295[CrossRef][Medline]. |
| 87. |
Kovacs, G. R., and B. Moss.
1996.
The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.
J. Virol.
70:6796-6802 |
| 88. |
Kozopas, K. M.,
T. Yang,
H. L. Buchan,
P. Zhou, and R. W. Craig.
1993.
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Proc. Natl. Acad. Sci. USA
90:3516-3520 |
| 89. |
Krieser, R. J., and A. Eastman.
1998.
The cloning and expression of human deoxyribonuclease II.
J. Biol. Chem.
273:30909-30914 |
| 90. | Kumar, S., and D. B. Boyle. 1990. Mapping of a major early/late gene of fowlpox virus. Virus Res. 15:175-185[CrossRef][Medline]. |
| 91. | Kumar, S., and D. B. Boyle. 1990. A poxvirus bidirectional promoter element with early/late and late functions. Virology 179:151-158[CrossRef][Medline]. |
| 92. |
Kupke, T.,
S. Stevanovic,
H.-G. Sahl, and F. Gotz.
1992.
Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin.
J. Bacteriol.
174:5354-5361 |
| 93. |
Laidlaw, S. M.,
M. A. Anwar,
W. Thomas,
P. Green,
K. Shaw, and M. A. Skinner.
1998.
Fowlpox virus encodes nonessential homologs of cellular alpha-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein.
J. Virol.
72:6742-6751 |
| 94. | Lalani, A. S., T. L. Ness, R. Singh, J. K. Harrison, B. T. Seet, D. J. Kelvin, G. McFadden, and R. W. Moyer. 1998. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250:173-184[CrossRef][Medline]. |
| 95. | Lange, C., T. Liehr, M. Goen, E. Gebhart, B. Fleckenstein, and A. Ensser. 1998. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 51:340-350[CrossRef][Medline]. |
| 96. |
Leong, K. H.,
A. J. Ramsay,
D. B. Boyle, and I. A. Ramshaw.
1994.
Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.
J. Virol.
68:8125-8130 |
| 97. |
Levi-Montalcini, R.
1987.
The nerve growth factor 35 years later.
Science
237:1154-1162 |
| 98. |
Lewis, T.,
L. Zsak,
T. G. Burrage,
Z. Lu,
G. F. Kutish,
J. G. Neilan, and D. L. Rock.
2000.
An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine.
J. Virol.
74:1275-1285 |
| 99. |
Liao, T.-H.
1985.
The subunit structure and active site sequence of porcine spleen deoxyribonuclease.
J. Biol. Chem.
260:10708-10713 |
| 100. | Lin, E. Y., A. Orlofsky, M. S. Berger, and M. B. Prystowsky. 1993. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151:1979-1988[Abstract]. |
| 101. |
Lin, J.-H.,
A. Makris,
C. McMahon,
S. E. Bear,
C. Patriotis,
V. R. Prasad,
R. Brent,
E. A. Golemis, and P. N. Tsichlis.
1999.
The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1.
J. Biol. Chem.
274:14706-14715 |
| 102. | Lux, S. E., K. M. John, and V. Bennett. 1990. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 34:36-42. |
| 103. |
Maa, J.-S.,
J. F. Rodriguez, and M. Esteban.
1990.
Structural and functional characterization of a cell surface binding protein of vaccinia virus.
J. Biol. Chem.
265:1569-1577 |
| 104. |
Marshall, J. S.,
K. Gomi,
M. G. Blennerhassett, and J. Bienenstock.
1999.
Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism.
J. Immunol.
162:4271-4276 |
| 105. | Martin, K. H., D. W. Grosenbach, C. A. Franke, and D. E. Hruby. 1997. Identification and analysis of three myristylated vaccinia virus late proteins. J. Virol. 71:5218-5226[Abstract]. |
| 106. | Massung, R. F., J. J. Esposito, L. I. Liu, J. Qi, T. R. Utterback, J. C. Knight, L. Aubin, T. E. Yuran, J. M. Parsons, V. N. Loparev, N. A. Selivanov, K. F. Cavallaro, A. R. Kerlavage, B. W. J. Mahy, and J. C. Venter. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366:748-751[CrossRef][Medline]. |
| 107. | Massung, R. F., V. Jayarama, and R. W. Moyer. 1993. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 197:511-528[CrossRef][Medline]. |
| 108. | Massung, R. F., L.-I. Liu, J. Qi, J. C. Knight, T. E. Yuran, A. R. Kerlavage, J. M. Parsons, J. C. Venter, and J. J. Esposito. 1994. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201:215-240[CrossRef][Medline]. |
| 109. |
Massung, R. F.,
G. McFadden, and R. W. Moyer.
1992.
Nucleotide sequence analysis of a unique near-terminal region of the tumorigenic poxvirus, Shope fibroma virus.
J. Gen. Virol.
73:2903-2911 |
| 110. | McFadden, G., K. Graham, and M. Barry. 1996. New strategies of immune modulation by DNA viruses. Transplant. Proc. 28:2085-2088[Medline]. |
| 111. | McIntosh, A. A., and G. L. Smith. 1996. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70:272-281[Abstract]. |
| 112. | McMillen, J. K., M. D. Cochran, D. E. Junker, D. N. Reddy, and D. M. Valencia. 1994. The safe and effective use of fowlpox virus as a vector for poultry vaccines. Dev. Biol. Stand. 82:137-145[Medline]. |
| 113. | Melchers, F., A. G. Rolink, and C. Schaniel. 1999. The role of chemokines in regulating cell migration during humoral immune responses. Cell 99:351-354[CrossRef][Medline]. |
| 114. | Micallef, M. J., T. Tanimoto, K. Torigoe, Y. Nishida, K. Kohno, H. Ikegami, and M. Kurimoto. 1999. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity. Cancer Immunol. Immunother. 48:109-117[CrossRef][Medline]. |
| 115. |
Mockett, B.,
M. M. Binns,
M. E. G. Boursnell, and M. A. Skinner.
1992.
Comparison of the locations of homologous fowlpox and vaccinia virus genes reveals major genome reorganization.
J. Gen. Virol.
73:2661-2668 |
| 116. | Moore, J. B., and G. L. Smith. 1992. Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J. 11:1973-1980[Medline]. |
| 117. | Morgan, A., and R. D. Burgoyne. 1995. A role for soluble NSF attachment proteins (SNAPs) in regulated exocytosis in adrenal chromaffin cells. EMBO J. 14:232-239[Medline]. |
| 118. | Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2671. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa. |
| 119. | Mossman, K., S. F. Lee, M. Barry, L. Boshkov, and G. McFadden. 1996. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70:4394-4410[Abstract]. |
| 120. |
Muller, H. K.,
R. Wittek,
W. Schaffner,
D. Schumperli,
A. Menna, and R. Wyler.
1978.
Comparison of five poxvirus genomes by analysis with restriction endonucleases HindIII, BamI and EcoRI.
J. Gen. Virol.
38:135-147 |
| 121. | Nazerian, K., R. L. Witter, L. F. Lee, and N. Yanagida. 1996. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:368-376[CrossRef][Medline]. |
| 122. |
Neilan, J. G.,
M. V. Borca,
Z. Lu,
G. F. Kutish,
S. B. Kleiboeker,
C. Carrillo,
L. Zsak, and D. L. Rock.
1999.
An African swine fever virus ORF with similarity to C-type lectins is non-essential for growth in swine macrophages in vitro and for virus virulence in domestic swine.
J. Gen. Virol.
80:2693-2697 |
| 123. |
Ogawa, R.,
J. G. Calvert,
N. Yanagida, and K. Nazerian.
1993.
Insertional inactivation of a fowlpox virus homologue of the vaccinia virus F12L gene inhibits the release of enveloped virions.
J. Gen. Virol.
74:55-64 |
| 124. | Omar, A. R., K. A. Schat, L. F. Lee, and H. D. Hunt. 1998. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 62:73-82[CrossRef][Medline]. |
| 125. |
Paoletti, E.
1996.
Applications of pox virus vectors to vaccination: an update.
Proc. Natl. Acad. Sci. USA
93:11349-11353 |
| 126. | Perkus, M. E., S. J. Goebel, S. W. Davis, G. P. Johnson, K. Limbach, E. K. Norton, and E. Paoletti. 1990. Vaccinia virus host range genes. Virology 179:276-286[CrossRef][Medline]. |
| 127. | Pollitt, E., M. A. Skinner, and S. Heaphy. 1998. Nucleotide sequence of the 4.3kbp BamHI-N fragment of fowlpox virus FP9. Virus Genes 17:5-9[CrossRef][Medline]. |
| 128. |
Purcell, D. A.,
J. K. Clarke,
J. B. McFerran, and D. A. Hughes.
1972.
The morphogenesis of pigeonpox virus.
J. Gen. Virol.
15:79-83 |
| 129. | Revardel, E., M. Bonneau, P. Durrens, and M. Aigle. 1995. Characterization of a new gene family developing pleiotropic phenotypes upon mutation in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1263:261-265[Medline]. |
| 130. |
Rodriguez, J. F., and G. L. Smith.
1990.
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.
Nucleic Acids Res.
18:5347-5351 |
| 131. |
Rosel, J. L.,
P. L. Earl,
J. P. Weir, and B. Moss.
1986.
Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.
J. Virol.
60:436-449 |
| 132. | Ryan, J. C., and W. E. Seaman. 1997. Divergent functions of lectin-like receptors on NK cells. Immunol. Rev. 155:79-89[CrossRef][Medline]. |
| 133. | Sadasiv, E. C., P. W. Chang, and G. Gulka. 1985. Morphogenesis of canary poxvirus and its entrance into inclusion bodies. Am. J. Vet. Res. 46:529-535[Medline]. |
| 134. |
Salzberg, S. L.,
A. L. Delcher,
S. Kasif, and O. White.
1998.
Microbial gene identification using interpolated Markov models.
Nucleic Acids Res.
26:544-548 |
| 135. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 136. | Sarma, D. K., and S. N. Sharma. 1988. Comparative immunity of fowlpox virus vaccines. J. Vet. Med. Biol. 35:19-23. |
| 137. | Saurin, A. J., K. L. B. Borden, M. N. Boddy, and P. S. Freemont. 1996. Does this have a familiar RING? Trends Biochem. Sci. 21:208-214[CrossRef][Medline]. |
| 138. | Scholzen, T., C. A. Armstrong, N. W. Bunnett, T. A. Luger, J. E. Olerud, and J. C. Ansel. 1998. Neuropeptides in the skin: interactions between the neuroendocrine and skin immune systems. Exp. Dermatol. 7:81-96[CrossRef][Medline]. |
| 139. | Schoneberg, T., G. Schultz, and T. Gudermann. 1999. Structural basis of G protein-coupled receptor function. Mol. Cell. Endocrinol. 151:181-193[CrossRef][Medline]. |
| 140. | Sedgwick, S. G., and S. J. Smerdon. 1999. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24:311-316[CrossRef][Medline]. |
| 141. | Senkevich, T. G., J. J. Bugert, J. R. Sisler, E. V. Koonin, G. Darai, and B. Moss. 1996. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273:813-816[Abstract]. |
| 142. | Senkevich, T. G., E. V. Koonin, J. J. Bugert, G. Darai, and B. Moss. 1997. The genome of Molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 233:19-42[CrossRef][Medline]. |
| 143. | Senkevich, T. G., E. V. Koonin, and R. M. L. Buller. 1994. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology 198:118-128[CrossRef][Medline]. |
| 144. | Senkevich, T. G., E. J. Wolffe, and R. M. L. Buller. 1995. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 69:4103-4111[Abstract]. |
| 145. | Shchelkunov, S. N., P. F. Safronov, A. V. Totmenin, N. A. Petrov, O. I. Ryazankina, V. V. Gutorov, and G. J. Kotwal. 1998. The genome sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243:432-460[CrossRef][Medline]. |
| 146. | Sheppard, M., W. Werner, E. Tsatas, R. McCoy, S. Prowse, and M. Johnson. 1998. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:915-930[CrossRef][Medline]. |
| 147. | Shida, H. 1986. Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150:451-462[CrossRef][Medline]. |
| 148. |
Shisler, J. L.,
T. G. Senkevich,
M. L. Berry, and B. Moss.
1998.
Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus.
Science
279:102-105 |
| 149. |
Shors, T.,
J. G. Keck, and B. Moss.
1999.
Down regulation of gene expression by the vaccinia virus D10 protein.
J. Virol.
73:791-796 |
| 150. |
Skinner, M. A.,
J. B. Moore,
M. M. Binns,
G. L. Smith, and M. E. G. Boursnell.
1994.
Deletion of fowlpox virus homologues of vaccinia virus genes between the 3 -hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes.
J. Gen. Virol.
75:2495-2498 |
| 151. |
Smith, C. A.,
T. Davis Smith,
P. J. Smolak,
D. Friend,
H. Hagen,
M. Gerhart,
L. Park,
D. J. Pickup,
D. Torrance,
K. Mohler,
K. Schooley, and R. G. Goodwin.
1997.
Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits chemokine activity yet lacks sequence homology to known chemokine receptors.
Virology
236:316-327[CrossRef][Medline].
|
| 152. |
Smith, G. L., and Y. S. Chan.
1991.
Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily.
J. Gen. Virol.
72:511-518 |
| 153. |
Spehner, D.,
S. Gillard,
R. Drillien, and A. Kirn.
1988.
A cowpox virus gene required for multiplication in Chinese hamster ovary cells.
J. Virol.
62:1297-1304 |
| 154. | Spriggs, M. K. 1999. Shared resources between the neural and immune systems: semaphorins join the ranks. Curr. Opin. Immunol. 11:387-391[CrossRef][Medline]. |
| 155. |
Staden, R., and A. D. McLachlan.
1982.
Codon preference and its use in identifying protein coding regions in long DNA sequences.
Nucleic Acids Res.
10:141-156 |
| 156. |
Staden, R.
1982.
An interactive graphics program for comparing and aligning nucleic acid and amino acid sequences.
Nucleic Acids Res.
10:2951-2961 |
| 157. | Stadtman, T. C. 1996. Selenocysteine. Annu. Rev. Biochem. 65:83-100[CrossRef][Medline]. |
| 158. | Stenbeck, G. 1998. Molecules in focus soluble NSF-attachment proteins. Int. J. Biochem. Cell Biol. 30:573-577[CrossRef][Medline]. |
| 159. |
Sutter, G.,
A. Ramsey-Ewing,
R. Rosales, and B. Moss.
1994.
Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
J. Virol.
68:4109-4116 |
| 160. | Sutton, G. G., O. White, M. D. Adams, and A. R. Kerlavage. 1995. TIGR assembler: a new tool for assembling large shotgun sequencing projects. Genome Sci. Tech. 1:9-19. |
| 161. | Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390[CrossRef][Medline]. |
| 162. | Tanaka-Kataoka, M., T. Kunikata, S. Takayama, K. Iwaki, K. Ohashi, M. Ikeda, and M. Kurimoto. 1999. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11:593-599[CrossRef][Medline]. |
| 163. |
Tartaglia, J.,
J. Winslow,
S. Goebel,
G. P. Johnson,
J. Taylor, and E. Paoletti.
1990.
Nucleotide sequence analysis of a 10.5 kbp HindIII fragment of fowlpox virus: relatedness to the central portion of the vaccinia virus HindIII D region.
J. Gen. Virol.
71:1517-1524 |
| 164. | Taylor, J., and E. Paoletti. 1988. Fowlpox virus as a vector in non-avian species. Vaccine 6:466-468[CrossRef][Medline]. |
| 165. | Taylor, J., R. Weinberg, J. Tartaglia, C. Richardson, G. Alkhatib, D. Briedis, M. Appel, E. Norton, and E. Paoletti. 1992. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187:321-328[CrossRef][Medline]. |
| 166. |
Tomley, F.,
M. Binns,
J. Campbell, and M. Boursnell.
1988.
Sequence analysis of an 11.2 kilobase, near-terminal, BamHI fragment of fowlpox virus.
J. Gen. Virol.
69:1025-1040 |
| 167. | Torcia, M., L. Bracci-Laudiero, M. Lucibello, L. Nencioni, D. Labardi, A. Rubartelli, F. Cozzolino, L. Aloe, and E. Garaci. 1996. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85:345-356[CrossRef][Medline]. |
| 168. |
Torriglia, A.,
P. Perani,
J. Y. Brossas,
E. Chaudun,
J. Treton,
Y. Courtois, and M. F. Counis.
1998.
L-DNase II, a molecule that links proteases and endonucleases in apoptosis, derives from the ubiquitous serpin leukocyte elastase inhibitor.
Mol. Cell. Biol.
18:3612-3619 |
| 169. | Tripathy, D. N. 1991. Pox, p. 583-596. In B. W. Calnek, H. J. Barnes, C. W. Beard, W. M. Reid, and H. W. Yoder, Jr. (ed.), Diseases of poultry, 9th ed. Iowa State University Press, Ames. |
| 170. | Tripathy, D. N., and C. H. Cunningham. 1984. Avian pox, p. 524-534. In M. S. Hofstad, H. J. Barnes, W. M. Reid, and H. W. J. Yoder (ed.), Diseases of poultry, 8th ed. Iowa State University Press, Ames. |
| 171. | Tripathy, D. N., and L. E. Hanson. 1978. Pathogenesis of fowlpox in laying hens. Avian Dis. 22:259-265[CrossRef][Medline]. |
| 172. | Turner, P. C., and R. W. Moyer. 1998. Control of apoptosis by poxviruses. Semin. Virol. 8:453-469. |
| 173. | VanSlyke, J. K., S. S. Whitehead, E. M. Wilson, and D. E. Hruby. 1991. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology 183:467-478[CrossRef][Medline]. |
| 174. |
Wang, C.-C.,
S.-C. Lu,
H.-L. Chen, and T.-H. Liao.
1998.
Porcine spleen deoxyribonuclease II.
J. Biol. Chem.
273:17192-17198 |
| 175. | Weis, W. I., M. E. Taylor, and K. Drickamer. 1998. The C-type lectin superfamily in the immune system. Immunol. Rev. 163:19-34[CrossRef][Medline]. |
| 176. | Welker, P., J. Grabbe, A. Grutzkau, and B. M. Henz. 1998. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 94:310-317[Medline]. |
| 177. | Weskamp, G., and U. Otten. 1987. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48:1779-1786[Medline]. |
| 178. |
Whitehead, S. S., and D. E. Hruby.
1994.
A transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K.
J. Virol.
68:7603-7608 |
| 179. |
Wilcock, D.,
S. A. Duncan,
P. Traktman,
W.-H. Zhang, and G. L. Smith.
1999.
The vaccinia virus A40R gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.
J. Gen. Virol.
80:2137-2148 |
| 180. |
Williams, A. F., and A. N. Barclay.
1988.
The immunoglobulin superfamily domains for cell surface recognition.
Annu. Rev. Immunol.
6:381-405[Medline].
|
| 181. |
Wolffe, E. J.,
S. N. Isaacs, and B. Moss.
1993.
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
J. Virol.
67:4732-4741 |
| 182. | Woodward, H., and D. C. Tudor. 1973. The immunizing effect of commercial pigeon pox vaccines on pigeons. Poult. Sci. 52:1463-1468[Medline]. |
| 183. |
Woolf, C. J.,
Q. P. Ma,
A. Allchorne, and S. Poole.
1996.
Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation.
J. Neurosci.
16:2716-2723 |
| 184. | Xiang, Y., and B. Moss. 1999. Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the Molluscum contagiosum poxvirus. Virology 257:297-302[CrossRef][Medline]. |
| 185. |
Xiang, Y., and B. Moss.
1999.
IL-18 binding and inhibition of interferon induction by human poxvirus encoded proteins.
Proc. Natl. Acad. Sci. USA
96:11537-11542 |
| 186. |
Xiang, Y.,
D. A. Simpson,
J. Spiegel,
A. Zhou,
R. H. Silverman, and R. C. Condit.
1998.
The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.
J. Virol.
72:7012-7023 |
| 187. |
Yanagida, N.,
R. Ogawa,
Y. Li,
L. F. Lee, and K. Nazerian.
1992.
Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.
J. Virol.
66:1402-1408 |
| 188. | Yasui, A., A. P. M. Eker, S. Yasuhira, H. Yajima, T. Kobayashi, M. Takao, and A. Oikawa. 1994. A new class of DNA photolyases present in various organisms including aplacental mammals. EMBO J. 13:6143-6151[Medline]. |
| 189. |
Yuen, L., and B. Moss.
1987.
Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes.
Proc. Natl. Acad. Sci. USA
84:6417-6421 |
| 190. | Zajac, P., D. Spehner, and R. Drillien. 1995. The vaccinia virus J5L open reading frame encodes a polypeptide expressed late during infection and required for viral multiplication. Virus Res. 37:163-173[CrossRef][Medline]. |
| 191. |
Zantinge, J. L.,
P. J. Krell,
J. B. Derbyshire, and E. Nagy.
1996.
Partial transcriptional mapping of the fowlpox virus genome and analysis of the EcoRI L fragment.
J. Gen. Virol.
77:603-614 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»